Latest reported quarter: Q1, ended Jun 2026
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.48B | $4.71B | $1.31B | $1.19B | $1.14B |
| Total Operating Revenue | $1.48B | $4.71B | $1.31B | $1.19B | $1.14B |
| Cost of Revenue | $545.80M | $1.99B | $511.60M | $479.10M | $502.50M |
| Gross Profit | $938.90M | $2.72B | $799.60M | $706.90M | $637.90M |
| Operating Expense | $583.20M | $2.19B | $575.80M | $550.40M | $542.70M |
| Selling and Admin Expenses | $184.30M | $674.30M | $174.20M | $168.50M | $172.30M |
| Research & Development | $308.90M | $1.09B | $293.80M | $274.30M | $262.30M |
| Depreciation & Amortization & Depletion | $90.00M | $431.10M | $107.80M | $107.60M | $108.10M |
| -Depreciation & Amortization | $90.00M | $431.10M | $107.80M | $107.60M | $108.10M |
| Operating Profit | $355.70M | $529.80M | $223.80M | $156.50M | $95.20M |
| Net Non-Operating Interest Income (Expense) | -$47.40M | -$209.90M | -$50.10M | -$54.60M | -$52.70M |
| Non-Operating Interest Income | $1.40M | $11.40M | $1.60M | $1.30M | $3.60M |
| Non-Operating Interest Expense | $46.50M | $215.40M | $49.80M | $54.60M | $55.00M |
| Total Other Finance Costs | $2.30M | $5.90M | $1.90M | $1.30M | $1.30M |
| Other Income (Expense) | -$18.40M | -$46.40M | -$9.80M | -$8.30M | -$10.70M |
| Special Income (Charges) | -$18.90M | -$39.70M | -$6.40M | -$4.80M | -$6.30M |
| -Less:Other Special Charges | $18.90M | $2.10M | -$31.20M | $4.80M | $6.30M |
| Other Non-Operating Income (Expenses) | $500,000.00 | -$6.70M | -$3.40M | -$3.50M | -$4.40M |
| Pretax Profit | $289.90M | $273.50M | $163.90M | $93.60M | $31.80M |
| Tax | $60.10M | $43.50M | $19.70M | $30.90M | -$9.90M |
| Net Profit | $229.80M | $230.00M | $144.20M | $62.70M | $41.70M |
| Profit from Continuing Operations | $229.80M | $230.00M | $144.20M | $62.70M | $41.70M |
| Net Income to Parent Company | $229.80M | $230.00M | $144.20M | $62.70M | $41.70M |
| Preferred Stock Dividends | $27.80M | $111.20M | $27.80M | $27.80M | $27.80M |
| Net Income to Common Stockholders | $202.00M | $118.80M | $116.40M | $34.90M | $13.90M |
| Basic EPS | $0.37 | $0.22 | $0.21 | $0.06 | $0.03 |
| Diluted EPS | $0.37 | $0.22 | $0.21 | $0.06 | $0.03 |
| Dividend Per Share | $0.46 | $1.82 | $0.46 | $0.46 | $0.46 |
| -Less:Restructuring and Mergern & Acquisition | – | $37.60M | – | – | – |
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Total Assets | $14.41B | $14.37B | $14.37B | $14.33B | $14.47B |
| Total Current Assets | $2.49B | $2.38B | $2.38B | $2.29B | $2.35B |
| Cash and Cash Equivalents & Short-Term Investments | $272.30M | $240.30M | $240.30M | $250.70M | $236.80M |
| -Cash and Cash Equivalents | $272.30M | $240.30M | $240.30M | $250.70M | $236.80M |
| Receivables | $967.70M | $894.70M | $894.70M | $731.20M | $746.20M |
| -Accounts Receivable | $957.10M | $889.70M | $889.70M | $697.60M | $737.00M |
| -Other Receivables | $15.90M | $10.30M | $10.30M | $39.20M | $14.80M |
| -Receivables Adjustments Allowances | -$5.30M | -$5.30M | -$5.30M | -$5.60M | -$5.60M |
| Inventory | $1.05B | $1.04B | $1.04B | $1.06B | $1.10B |
| Other Current Assets | $198.90M | $207.20M | $207.20M | $251.00M | $272.00M |
| Total Non-Current Assets | $11.92B | $11.99B | $11.99B | $12.03B | $12.12B |
| Net PPE | $1.08B | $1.11B | $1.11B | $1.13B | $1.15B |
| -Gross PPE | $3.72B | $3.71B | $3.71B | $3.68B | $3.67B |
| -Accumulated Depreciation | -$2.64B | -$2.60B | -$2.60B | -$2.55B | -$2.52B |
| Goodwill and Other Intangible Assets | $8.70B | $8.73B | $8.73B | $8.79B | $8.87B |
| -Goodwill | $6.70B | $6.70B | $6.70B | $6.70B | $6.70B |
| -Other Intangible Assets | $2.00B | $2.03B | $2.03B | $2.10B | $2.17B |
| Non-Current Deferred Assets | $1.78B | $1.79B | $1.79B | $1.74B | $1.74B |
| Other Non-Current Assets | $358.10M | $364.40M | $364.40M | $367.80M | $361.90M |
| Total Liabilities | $7.96B | $7.94B | $7.94B | $7.77B | $7.77B |
| Total Current Liabilities | $1.29B | $1.14B | $1.14B | $1.06B | $1.04B |
| Payables | $272.00M | $229.90M | $229.90M | $160.60M | $170.00M |
| -Accounts Payable | $228.90M | $205.60M | $205.60M | $160.60M | $170.00M |
| -Total Tax Payable | $43.10M | $24.30M | $24.30M | $0.00 | $0.00 |
| Current Accrued Expenses | $269.50M | $217.80M | $217.80M | $223.60M | $211.00M |
| Short-Term Debt and Capital Lease Obligation | $37.40M | $38.80M | $38.80M | $38.60M | $36.80M |
| -Current Capital Lease Obligation | $37.40M | $38.80M | $38.80M | $38.60M | $36.80M |
| Current Provisions | $377.00M | $338.50M | $338.50M | $339.50M | $349.00M |
| Current Deferred Liabilities | $174.20M | $179.20M | $179.20M | $163.00M | $160.00M |
| Total Non-Current Liabilities | $6.66B | $6.80B | $6.80B | $6.71B | $6.73B |
| Long Term Accounts Payable and Other Payables | $580.20M | $570.90M | $570.90M | $572.70M | $561.10M |
| Long Term Debt and Capital Lease Obligation | $5.36B | $5.50B | $5.50B | $5.37B | $5.38B |
| -Long Term Debt | $5.36B | $5.50B | $5.50B | $5.37B | $5.38B |
| Non-Current Deferred Liabilities | $25.40M | $25.10M | $25.10M | $29.60M | $35.20M |
| Other Non-Current Liabilities | $695.10M | $709.00M | $709.00M | $737.50M | $758.20M |
| Total Equity | $6.45B | $6.43B | $6.43B | $6.56B | $6.70B |
| Stockholders' Equity | $6.45B | $6.43B | $6.43B | $6.56B | $6.70B |
| Capital Stock | $600,000.00 | $600,000.00 | $600,000.00 | $600,000.00 | $600,000.00 |
| -Common Stock | $600,000.00 | $600,000.00 | $600,000.00 | $600,000.00 | $600,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $4.12B | $4.07B | $4.07B | $4.09B | $4.03B |
| Retained Earnings | $4.87B | $4.92B | $4.92B | $5.05B | $5.26B |
| Less: Treasury Stock | $2.53B | $2.55B | $2.55B | $2.57B | $2.58B |
| Gains/Losses Not Affecting Retained Earnings | -$3.70M | -$4.20M | -$4.20M | -$6.70M | -$6.20M |
| Line item | 2027 Q1 | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 |
|---|---|---|---|---|---|
| Operating Cash Flow | $511.50M | $962.10M | $257.00M | $341.40M | $88.10M |
| Net cash flow from continuing operations | $511.50M | $962.10M | $257.00M | $341.40M | $88.10M |
| Net Income from Continuing Operations | $229.80M | $230.00M | $144.20M | $62.70M | $41.70M |
| Depreciation & Depletion & Amortization | $156.70M | $689.30M | $173.70M | $171.80M | $172.70M |
| Deferred Tax | $11.40M | -$64.60M | -$51.30M | -$15.60M | $5.30M |
| Other Non-Cash Items | $2.50M | $15.60M | $300,000.00 | $1.70M | $11.40M |
| Change in Working Capital | $36.00M | -$167.70M | -$79.80M | $48.20M | -$204.90M |
| -Change in Receivables | -$73.10M | -$204.50M | -$163.60M | $15.00M | $19.90M |
| -Change in Inventory | -$9.20M | $264.30M | $24.30M | $39.00M | $76.00M |
| -Change in Payables and Accrued Expense | $146.30M | -$121.70M | $73.20M | $10.50M | -$228.40M |
| -Change In Other Working Capital | -$28.00M | -$105.80M | -$13.70M | -$16.30M | -$72.40M |
| Net cash flow from investing | -$52.00M | -$195.50M | -$52.10M | -$44.50M | -$62.00M |
| Net Cash Flow from Continuing Investing Activities | -$52.00M | -$195.50M | -$52.10M | -$44.50M | -$62.00M |
| Capital Expenditure | -$13.90M | -$91.10M | -$14.20M | -$22.50M | -$36.50M |
| Net Other Investing Changes | -$38.10M | -$104.40M | -$37.90M | -$22.00M | -$25.50M |
| Financing Cash Flow | -$427.50M | -$1.30B | -$215.30M | -$283.00M | -$355.80M |
| Net Cash Flow from Continuing Financing Activities | -$427.30M | -$1.30B | -$215.30M | -$283.00M | -$355.80M |
| Net Issuance Payments Of Debt | -$138.00M | -$127.90M | $146.30M | -$11.70M | -$88.00M |
| Net Common Stock Issuance | $13.00M | $61.70M | $19.20M | $12.20M | $17.90M |
| Cash Dividends Paid | -$274.70M | -$1.09B | -$274.40M | -$273.90M | -$273.60M |
| Net Other Financing Charges | -$27.80M | -$71.30M | -$38.40M | -$9.60M | -$12.10M |
| Ending Cash Balance | $272.30M | $240.30M | $240.30M | $250.70M | $236.80M |
| Net Change in Cash | $32.00M | -$531.40M | -$10.40M | $13.90M | -$329.70M |
| Beginning Cash Balance | $240.30M | $771.70M | $250.70M | $236.80M | $566.50M |
| Free Cash Flow | $497.60M | $871.00M | $242.80M | $318.90M | $51.60M |
| Net Preferred Stock Issuance | – | $0.00 | – | – | – |
| Proceeds from Stock Option Exercised | – | -$68.00M | -$68.00M | $0.00 | – |
No comments yet — be the first to weigh in on MCHP.